Federal Register / Vol. 71, No.
203 / Friday, October 20, 2006 / Notices 62017
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–274N]
Solicitation of Information on the Use
of Phenethylamine-Related
Compounds
AGENCY: Drug Enforcement
Administration (DEA), Department of
Justice.
ACTION: Notice, solicitation of
information.
SUMMARY: The DEA is soliciting
information on substances that are
related in chemical structure to
phenethylamine (see supplementary
information). The Controlled Substances
Act (CSA), Title 21 of the United States
Code (U.S.C.) § 812(c) schedule I (Title
21 of the Code of Federal Regulations
(CFR) § 1308.11(d)), lists certain
phenethylamines as schedule I
controlled substances. Some
phenethylamines that are not controlled
under the CSA produce central nervous
system effects that are similar to
phenethylamines that are controlled
under the CSA. DEA is requesting
information to help determine the
impact on business if these substances
were to be placed under control in the
CSA.
DATES: Written comments must be
postmarked, and electronic comments
must be sent, on or before December 19,
2006.
ADDRESSES: To ensure proper handling
of comments, please reference ‘‘Docket
No. DEA–274N’’ on all written and
electronic correspondence. Written
comments being sent via regular mail
should be sent to the Deputy Assistant
Administrator, Office of Diversion
Control, Drug Enforcement
Administration, Washington, DC 20537,
Attention: DEA Federal Register
Representative/ODL. Written comments
sent via express mail should be sent to
DEA Headquarters, Attention: DEA
Federal Register Representative/ODL,
2401 Jefferson-Davis Highway,
Alexandria, VA 22301. Comments may
be directly sent to DEA electronically by
sending an electronic message to
dea.diversion.policy@usdoj.gov. DEA
will accept attachments to electronic
comments in Microsoft Word,
WordPerfect, Adobe PDF, or Excel file
formats only. DEA will not accept any
file format other than those specifically
jlentini on PROD1PC65 with NOTICES
listed here.
FOR FURTHER INFORMATION CONTACT:
Christine A. Sannerud, Ph.D., Chief,
Drug and Chemical Evaluation Section,
Office of Diversion Control, Drug
VerDate Aug<31>2005 15:52 Oct 19, 2006 Jkt 211001
Enforcement Administration,
Washington, DC 20537; Telephone:
(202) 307–7183.
SUPPLEMENTARY INFORMATION:
Phenethylamine is a compound in
which the chemical structure is a
benzene ring substituted with a 2-
aminoethyl chain. Although
phenethylamine itself is not a controlled
substance, its chemical structure
constitutes the skeletal makeup of
phenethylamines listed in schedule I of
the CSA, which are classified as
hallucinogenic substances.
Phenethylamines are also found in
schedule II and IV of the CSA.
Phenethylamine is sometimes
substituted on the benzene ring or the
2-aminoethyl chain or both with various
substituents. Title 21 CFR 1308.11(d)
lists specific substituted
phenethylamines in schedule I. Also
included in schedule I are the salts,
isomers, and salts of isomers of the
listed phenethylamines. The term
isomer, as used in this section, means
the optical, geometric, and positional
isomers.
Individuals have published detailed
methods of synthesis for substituted
phenethylamines and have reported
pharmacological effects based on user
experiences. Law enforcement
personnel encounter such
phenethylamines, but because they are
substituted differently than those listed
or described in the CSA, they are not
subject to direct control in schedule I.
However, some of these substances can
be treated as schedule I controlled
substance analogues if intended for
human consumption (21 U.S.C. 802(32);
813).
DEA is soliciting information on (1)
the commercial uses for
phenethylamines, (2) activities
involving research and development, (3)
phenethylamines as intermediates or
analytical standards, (4) import and
domestic sources for phenethylamines,
and (5) any planned or anticipated uses
for phenethylamines. DEA invites
interested persons to provide any
information on the uses of
phenethylamines in industry, academia,
research and development, or other
applications. Both quantitative and
qualitative information are sought.
Although information is requested for
all phenethylamine substances
regardless of substitutions, DEA is
particularly interested in
phenethylamines that meet one or more
of the following conditions: any
compound structurally derived from
phenethylamine, or from any N-
alkylphenethylamine, any alpha-
alkylphenethylamine, or any N-alkyl-
PO 00000 Frm 00072 Fmt 4703 Sfmt 4703 E:\FR\FM\20OCN1.SGM
alpha-alkylphenethylamine, by
substitution on the ring to any extent
with alkyl, cycloalkyl, cycloalkenyl,
alkoxy, alkylthio, alkylhalide, alkylene-
dioxy, acyloxy, or halide substituents,
whether or not further substituted on
the ring by one or more other univalent
substituents. DEA is especially
interested in learning of the uses of the
following phenethylamines:
1,4-Dimethoxynaphthyl-2-ethylamine
1,4-Dimethoxynaphthyl-2-isopropylamine
2-(2,5-Dimethoxy-4-methylphenyl)-
cyclopropylamine
2,3,4,5-Tetramethoxyamphetamine
2,3,4-Trimethoxyamphetamine
2,3,4-Trimethoxyphenethylamine
2,3,5-Trimethoxyamphetamine
2,3,6-Trimethoxyamphetamine
2,3-Dimethoxy-4,5-
methylenedioxyamphetamine
2,4,5-Triethoxyamphetamine
2,4,5-Trimethoxyamphetamine
2,4,5-Trimethoxyphenethylamine
2,4,6-Trimethoxyamphetamine
2,4-Diethoxy-5-methoxyamphetamine
2,4-Dimethoxy-5-ethoxyamphetamine
2,4-Dimethoxyamphetamine
2,5,beta-Trimethoxy-4-
methylphenethylamine
2,5-Bismethylthio-4-methylamphetamine
2,5-Diethoxy-4-methoxyamphetamine
2,5-Dimethoxy-3,4-
methylenedioxyamphetamine
2,5-Dimethoxy-4,N-dimethylamphetamine
2,5-Dimethoxy-4-ethoxyamphetamine
2,5-Dimethoxy-4-propoxyamphetamine
2,5-Dimethoxy-alpha-ethyl-4-
methylphenethylamine
2,5-Dimethoxy-beta-hydroxy-4-
methylphenethylamine
2,5-Dimethoxy-N,N-dimethyl-4-
iodoamphetamine
2,5-Dimethoxy-N-hydroxy-4-(n)-
propylthiophenethylamine
2,5-Dimethoxy-N-hydroxy-4-(sec)-
butylthiophenethylamine
2,5-Dimethoxy-N-hydroxy-4-
ethylthiophenethylamine
2,5-Dimethoxyphenethylamine
2,N-Dimethyl-4,5-
methylenedioxyamphetamine
2-Bromo-4,5-methylenedioxyamphetamine
2-Ethoxy-4,5-dimethoxyamphetamine
2-Methoxy-3,4-methylenedioxyamphetamine
2-Methoxy-4,5-diethoxyamphetamine
2-Methoxy-4,5-methylenedioxyamphetamine
2-Methoxy-4-methyl-5-
methylsulfinylamphetamine
2-Methoxy-4-methyl-5-
methylthioamphetamine
2-Methylthio-3,4-dimethoxyphenethylamine
2-Methylthio-3,4-
methylenedioxyamphetamine
2-Methylthio-4,5-dimethoxyamphetamine
3,4,5,beta-Tetramethoxyphenethylamine
3,4,5-Triethoxyphenethylamine
3,4,5-Trimethoxyphenethylamine
3,4-Diethoxy-5-methoxyphenethylamine
3,4-Diethoxy-5-methylthiophenethylamine
3,4-Dimethoxy-5-ethoxyphenethylamine
3,4-Dimethoxy-5-propoxyphenethylamine
3,4-Dimethoxyamphetamine
3,4-Dimethoxy-beta-hydroxyphenethylamine
3,4-Dimethoxyphenethylamine
20OCN1
 62018 Federal Register / Vol. 71, No. 203 / Friday, October 20, 2006 / Notices

3,4-Dimethyl-2,5-dimethoxyamphetamine 4-Ethyl-5-methoxy-2- N-Methyl-2-methoxy-4,5-

3,4-Dimethyl-2,5-dimethoxyphenethylamine methylthioamphetamine methylenedioxyamphetamine
3,4-Ethylenedioxy-5-methoxyamphetamine 4-Ethylthio-2,5-dimethoxyamphetamine N-Methyl-3,4-ethylenedioxyamphetamine
3,4-Methylenedioxyphenethylamine 4-Ethylthio-2,5-dimethoxyphenethylamine N-Methyl-4-methoxyamphetamine
3,4-Norbornyl-2,5-dimethoxyamphetamine 4-Fluoro-2,5-dimethoxyphenethylamine N-Methyl-alpha-ethyl-3,4-
3,4-Norbornyl-2,5-dimethoxyphenethylamine 4-Iodo-2,5-dimethoxyamphetamine methylenedioxyphenethylamine
3,4-Tetramethylene-2,5- 4-Iodo-2,5-dimethoxyphenethylamine N-Methyl-alpha-propyl-3,4-
dimethoxyamphetamine 4-Isopropoxy-2,5-dimethoxyphenethylamine methylenedioxyphenethylamine
3,4-Tetramethylene-2,5- 4-Isopropylthio-2,5-dimethoxyamphetamine N-Propargyl-3,4-
dimethoxyphenethylamine 4-Isopropylthio-2,5- methylenedioxyamphetamine
3,4-Trimethylene-2,5- dimethoxyphenethylamine N-Propyl-3,4-methylenedioxyamphetamine
dimethoxyamphetamine 4-Isopropylthio-2,6-
3,4-Trimethylene-2,5- dimethoxyphenethylamine Such information may be submitted to
dimethoxyphenethylamine 4-Methoxy-2,3-methylenedioxyamphetamine the Drug Enforcement Administration
3,5-Diethoxy-4-ethylthiophenethylamine 4-Methyl-2,5-dimethoxyphenethylamine using the information in the ADDRESSES
3,5-Diethoxy-4-methoxyphenethylamine 4-Methyl-2,6-dimethoxyamphetamine section above. Such information is
3,5-Diethoxy-4-methylthiophenethylamine 4-Methyl-3,5-Dimethoxyphenethylamine requested on or before December 19,
3,5-Dimethoxy-4-ethylthiophenethylamine 4-Methylseleno-2,5- 2006. Information designated as
3,5-Dimethoxy-4-isopropoxyphenethylamine dimethoxyphenethylamine
3,5-Dimethoxy-4- confidential or proprietary will be
4-Methylthio-2,3-dimethoxyphenethylamine
methallyloxyphenethylamine 4-Methylthio-2,5-dimethoxyamphetamine
treated accordingly. Confidential
3,5-Dimethoxy-4- 4-Methylthio-2,5-dimethoxyphenethylamine business information is protected from
phenethyloxyphenethylamine 4-Methylthio-3,5-dimethoxyphenethylamine disclosure under Exemption 4 of the
3,5-Dimethoxy-4-propoxyphenethylamine 4-Nitro-2,5-dimethoxyamphetamine Freedom of Information Act, 5 U.S.C.
3-Ethoxy-4-ethylthio-5- 4-Nitro-2,5-dimethoxyphenethylamine 552(b)(4)(FOIA) and the Department of
methoxyphenethylamine 4-Phenylthio-2,5-dimethoxyamphetamine Justice procedures set forth in 28 CFR
3-Ethoxy-4-methoxy-5- 4-Propyl-2,5-dimethoxyamphetamine
methylthiophenethylamine 16.8.
4-Propyl-2,5-dimethoxyphenethylamine
3-Ethoxy-5-ethylthio-4- 4-Propylthio-2,5-dimethoxyamphetamine Dated: October 11, 2006.
methoxyphenethylamine 4-Propylthio-3,5-dimethoxyphenethylamine Joseph T. Rannazzisi,
3-Ethoxy-5-methoxy-4- 4-Propynyloxy-3,5- Deputy Assistant Administrator, Office of
methylthiophenethylamine
dimethoxyphenethylamine Diversion Control.
3-Methoxy-4,5-
4-Thiobutoxy-3,5-dimethoxyphenethylamine [FR Doc. E6–17523 Filed 10–19–06; 8:45 am]
methylenedioxyphenethylamine
4-Trideuteromethyl-3,5-
3-Methoxy-4-ethoxyphenethylamine BILLING CODE 4410–09–P
dimethoxyphenethylamine
3-Methylthio-2,4-dimethoxyphenethylamine
5-Bromo-2,4-dimethoxyamphetamine
3-Methylthio-4,5-dimethoxyphenethylamine
4-(2-Fluoroethyl)-2,5- 5-Ethoxy-2-methoxy-4-methylamphetamine
5-Methoxy-4-methyl-2- DEPARTMENT OF JUSTICE
dimethoxyamphetamine
4-(2-Fluoroethylthio)-2,5- methylthioamphetamine
5-Methylthio-2,4-dimethoxyamphetamine Federal Bureau of Investigation
dimethoxyphenethylamine
4-(2-Methoxyethylthio)-2,5- alpha,alpha,N-Trimethyl-3,4- [OMB Number 1110–0001]
dimethoxyphenethylamine methylenedioxyphenethylamine
4-(sec)-Butylthio-2,5- alpha,alpha-Dimethyl-3,4- Agency Information Collection
dimethoxyphenethylamine methylenedioxyphenethylamine Activities: Proposed Collection,
4-(tert)-Butylthio-2,5- alpha-Ethyl-3,4,5-trimethoxyphenethylamine
Comments Requested
dimethoxyphenethylamine alpha-Ethyl-3,4-
4,5-Diethoxy-3-ethylthiophenethylamine methylenedioxyphenethylamine
ACTION: 30-day Notice of Information
4,5-Dimethoxy-3-ethylthiophenethylamine Benzofuran-2,2-dimethyl-5-methoxy-6-(2-
aminopropane) Collection Under Review: Revision of a
4,5-Thiomethyleneoxy-2- currently approved collection Return
methoxyamphetamine Benzofuran-2-methyl-5-methoxy-6-(2-
4-Allyloxy-3,5-dimethoxyphenethylamine aminopropane) A—Monthly Return of Offenses Known
4-Amyl-2,5-dimethoxyamphetamine beta,beta-Dideutero-3,4,5- to the Police; Supplement to Return A—
4-Benzyloxy-3,5-dimethoxyamphetamine trimethoxyphenethylamine Monthly Return of Offenses Known to
4-Bromo-2,5,beta-trimethoxyphenethylamine beta-Methoxy-3,4- the Police.
4-Bromo-2,5-dimethoxy-N- methylenedioxyphenethylamine
methylamphetamine N-(2-Hydroxyethyl)-3,4- The Department of Justice, Federal
4-Bromo-3,5-dimethoxyamphetamine methylenedioxyamphetamine Bureau of Investigation, Criminal Justice
4-Butoxy-3,5-dimethoxyphenethylamine N-(2-Methoxyethyl)-3,4- Information Services Division has
4-Butyl-2,5-dimethoxyamphetamine methylenedioxyamphetamine submitted the following information
4-Chloro-2,5-dimethoxyamphetamine N,alpha-diethyl-3,4-
collection request to the Office of
4-Chloro-2,5-dimethoxyphenethylamine methylenedioxyphenethylamine
N,N-Dimethyl-3,4- Management and Budget (OMB) for
4-Cyclopropylmethoxy-3,5-
dimethoxyphenethylamine methylenedioxyamphetamine review and clearance in accordance
4-Cyclopropylmethylthio-2,5- N-Allyl-3,4-methylenedioxyamphetamine with established review procedures of
dimethoxyphenethylamine N-Benzyl-3,4-methylenedioxyamphetamine the Paperwork Reduction Act of 1995.
4-Cyclopropylthio-2,5- N-Butyl-3,4-methylenedioxyamphetamine The proposed information collection is
dimethoxyphenethylamine N-Cyclopropylmethyl-3,4- published to obtain comments from the
4-Ethoxy-3,5-dimethoxyamphetamine methylenedioxyamphetamine public and affected agencies. This
4-Ethoxy-3,5-dimethoxyphenethylamine N-Ethyl-alpha-propyl-3,4- proposed information collection was
4-Ethoxy-3-ethylthio-5- methylenedioxyphenethylamine
previously published in the Federal
jlentini on PROD1PC65 with NOTICES

methoxyphenethylamine N-Hydroxy-N-methyl-3,4-
4-Ethoxy-5-methoxy-3- methylenedioxyamphetamine Register on April 27, 2006, Volume 71,
methylthiophenethylamine N-Isopropyl-3,4- Number 81, Pages 24868–24869
4-Ethyl-2,5-dimethoxyphenethylamine methylenedioxyamphetamine allowing for a 60-day comment period.
4-Ethyl-2-methoxy-5- N-Methoxy-3,4-methylenedioxyamphetamine The purpose of this notice is to allow
methylthioamphetamine N-Methyl-2,5-dimethoxyamphetamine for an additional 30 days for public

VerDate Aug<31>2005 15:52 Oct 19, 2006 Jkt 211001 PO 00000 Frm 00073 Fmt 4703 Sfmt 4703 E:\FR\FM\20OCN1.SGM 20OCN1